An ECHA study has examined the value of a chemical without negative health effects to us. The significance of the study, which has been ongoing since 2012, was presented at an ECHA workshop in January. The study assigns concrete costs to specific health endpoints, such as cancer. The starting point is always the question, What would you be willing to pay to avoid something like cancer or sterility?
These kinds of numbers may be useful for socioeconomic analyses. The analyses might be the basis of better evaluations and ratings of limitations and approvals in the context of REACH.
If you have questions about REACH, we are always pleased to help. Contact us at email@example.com.